References of "Boonen, A"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailPreferences of patients for osteoporosis drug treatment: a cross-european discrete choice experiment
Hiligsmann, Mickaël ULg; Dellaert, BG; Dirksen, CD et al

in Osteoporosis International (2014), 25(2), 227-228

Detailed reference viewed: 16 (1 ULg)
Full Text
Peer Reviewed
See detailPatients' preferences for osteoporosis drug therapy : a discrete choice experiment
Hiligsmann, Mickaël ULg; Dellaert, B; Dirksen, C et al

in Osteoporosis International (2013), 24(1), 53

Detailed reference viewed: 11 (3 ULg)
Full Text
Peer Reviewed
See detailWhat are the most important medication attributes for patients with osteoporosis ? Results from a qualitative study
Hiligsmann, Mickaël ULg; Van Durme, C; Geusens, P et al

in Osteoporosis International (2012, March), 23(S2), 81-82

Detailed reference viewed: 22 (3 ULg)
Full Text
Peer Reviewed
See detailQuelles sont les caractéristiques des médicaments les plus importantes pour les patients ostéoporotiques ? Résultats d'une étude qualitative
Hiligsmann, Mickaël ULg; Van Durme, C; Geusens, P et al

in Revue du Rhumatisme (2012), 79(S1), 238

Detailed reference viewed: 10 (4 ULg)
Full Text
Peer Reviewed
See detailNominal group technique to prioritize preferences for medication attributes from the patients’ perspective : the case of osteoporosis
Hiligsmann, Mickaël ULg; Van Durme, C; Geusens, P et al

in Annals of the Rheumatic Diseases (2012), 71(3), 597

Detailed reference viewed: 30 (5 ULg)
Full Text
Peer Reviewed
See detailHealthcare consumption and direct costs of rheumatoid arthritis in Belgium
Westhovens, R.; Boonen, A.; Verbruggen, L. et al

in Clinical Rheumatology (2005), 24(6), 615-619

The aim of this study was to compare the socioeconomic consequences of early and late rheumatoid arthritis in Belgium and to assess the patient out-of-pocket contributions. This multicentre longitudinal ... [more ▼]

The aim of this study was to compare the socioeconomic consequences of early and late rheumatoid arthritis in Belgium and to assess the patient out-of-pocket contributions. This multicentre longitudinal study in Belgium evaluated patients with rheumatoid arthritis. Early disease was defined as diagnosis since less than 1 year. At baseline sociodemographic and disease characteristics were assessed and during the following year patients recorded all healthcare- and non-healthcare-related direct costs and out-of-pocket contributions. The study included 48 patients with early and 85 patients with late rheumatoid arthritis. Mean disease duration was 0.5 vs 12.5 years in patients with early and late rheumatoid arthritis, respectively. The disease activity score (DAS28) was comparable between both groups (4.1 vs 4.5, p=0.14), but physical function (Health Assessment Questionnaire, HAQ) was more impaired in patients with long-standing disease (1.0 vs 1.7, p < 0.001). Work disability had increased from 2% in patients with early to 18% in patients with late disease. The annual societal direct costs per patient were E 3055 (median: E 1518) opposed to E 9946 (median: E 4017) for early and late rheumatoid arthritis, respectively. The higher direct cost for patients with long-standing disease was seen for all categories, but especially for physiotherapy and need for devices and adaptations. Patients with early as well as late disease contribute out of pocket about one-third to the direct healthcare costs. Within each group, HAQ was a strong determinant of costs. In Belgium, patients with long-standing rheumatoid arthritis are nine times more likely to be work disabled than patients with less than 1 year disease duration and have a threefold increase in costs. Differences in healthcare consumption between patients could be mainly explained by differences in physical function (HAQ). [less ▲]

Detailed reference viewed: 13 (0 ULg)
Peer Reviewed
See detailTaqI restriction fragment length polymorphism for bovine growth hormone in bovine breeds selected for milk and/or meat.
Renaville, Robert ULg; Sneyers, Myriam; Falaki, Mohammed et al

Poster (1994)

Detailed reference viewed: 5 (0 ULg)
Peer Reviewed
See detailTaqI restriction fragment length polymorphism for bovine growth hormone in bovine breeds selected for milk and/or meat
Renaville, Robert ULg; Sneyers, Myriam; Falaki, Mohammed et al

Poster (1994)

Detailed reference viewed: 6 (0 ULg)
Peer Reviewed
See detailTaqI restriction fragment length polymorphism for bovine growth hormone in bovine breeds selected for milk and/or meat
Renaville, Robert ULg; Sneyers, Myriam; Falaki, Mohammed et al

in Journal of Animal Science (1994), 72(suppl 1), 316

Detailed reference viewed: 4 (0 ULg)